Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Theratechnologies ( (TSE:TH) ) has provided an announcement.
Theratechnologies has completed its acquisition by Future Pak, with all common shares acquired for $3.01 per share in cash, plus a contingent value right (CVR) for potential additional payments. This acquisition will lead to the delisting of Theratechnologies’ shares from the Toronto Stock Exchange and Nasdaq, and the company will cease to be a reporting issuer under Canadian securities laws, marking a significant shift in its market presence.
The most recent analyst rating on (TSE:TH) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on Theratechnologies stock, see the TSE:TH Stock Forecast page.
Spark’s Take on TSE:TH Stock
According to Spark, TipRanks’ AI Analyst, TSE:TH is a Neutral.
Theratechnologies’ overall score is driven by positive corporate events, including a favorable acquisition agreement, which boosts shareholder value. Strong technical indicators also support the stock’s outlook. However, financial performance and valuation challenges, such as negative equity and a lack of profitability, weigh on the score.
To see Spark’s full report on TSE:TH stock, click here.
More about Theratechnologies
Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care.
Average Trading Volume: 52,391
Technical Sentiment Signal: Hold
Current Market Cap: C$215.6M
Learn more about TH stock on TipRanks’ Stock Analysis page.